Saint Thomas Midtown Hospital, formerly known as Baptist Hospital, is a not-for-profit community hospital in Nashville, Tennessee, United States and the largest such hospital in Middle Tennessee. It is licensed for 683 acute and rehab care beds.

There are 683 beds in St. Thomas Hospital.

During the past decade, St. Thomas Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 24 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 17 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Thomas Hospital" #1 sponsor was "Abbott Medical Devices" with 22 trials, followed by "Edwards Lifesciences" with 9 trials sponsored, "Boston Scientific Corporation" with 6 trials sponsored, "Vanderbilt-Ingram Cancer Center" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Thomas Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "National Institute on Aging (NIA)" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "St. Thomas Hospital" are "Heart Failure" (16 trials), "Mitral Regurgitation" (7 trials), "Aortic Valve Stenosis" (5 trials), "Lung Cancer" (5 trials) and "Mitral Valve Insufficiency" (5 trials). Many other conditions were trialed in "St. Thomas Hospital" in a lesser frequency.

Most popular intervention types in "St. Thomas Hospital" are "Device" (50 trials), "Drug" (20 trials), "Other" (10 trials), "Procedure" (7 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "Control" (2 trials), "HeartMate 3 LVAS" (2 trials) and "MitraClip System" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Thomas Hospital" are 77 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "St. Thomas Hospital". undefined are not yet recruiting, 12 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in St. Thomas Hospital, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in St. Thomas Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 40 trials that are defined as “Not Applicable".